Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on October 22, 2026

Sustaira Launches AI Agent Factory and Control Console to Accelerate Sustainability Impact
RAPIDÉ Brings Cold Immersion, Sauna and Recovery Technologies Together
RAPIDÉ Outlines Corporate Musculoskeletal Wellbeing Programme Concept
Poland's Ministry of Health Signs Agreement with HealthAI, Advancing Responsible AI Governance in Health Across Europe
Top Valves Manufacturer United Brothers Expands Stainless Steel Flow Control Solutions
Keyajee Ayurvedic Clinic Details Pregnancy Care and Childbirth Preparation in London
Miracle Surrogacy to Attend ASRM 2026 Congress, Expo and President’s Gala in Baltimore
Childhood Encounter With Death Leads Nicole Briggs-Gary to Help Families Navigate Life's Final Moments
After Doctors Told Her to Prepare for Death, Kristin Whitcomb Shares Her Illness Journey in International Bestseller
Five Reputable Nutraceutical Ingredient Manufacturers in China 2026: Advancing Nutrition Science
Top-Journal Breakthrough (IF=81.2): Cloud-Clone AGE ELISA Kit Helps Uncover Protein Glycation Modification
Global Market Forecast for Real-Time Follicle Counting AI Ultrasound Probes to Exceed $0.91 Billion by 2030
Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
Persica Pharmaceuticals presents antibiotic exposure-response analysis at the International Society of Pain & Neuroscience (ISPN) Annual Conference
Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidance
Ipsen réalise une croissance remarquable des ventes au cours des neuf premiers mois de 2026 et relève à nouveau ses prévisions pour l’exercice en cours
Pharming Group announces third quarter 2026 revenues above market expectations
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
Molecular Partners Nominates MP0730 as Next Candidate in Expanding Pipeline of Radiotherapeutics, Targeting CD70

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.